Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GLYCOMIMETICS INC | 40,000 | reported | 01 May 2024 | tx 29+2,533,951−578,358 |
| Fulcrum Therapeutics, Inc. | 36,000 | reported | 26 Jun 2025 | tx 2+96,000 |
| NOVAVAX INC | 28,326 | reported | 20 Jun 2025 | tx 31+403,630−35,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 28,326 | 6.42 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 18,884 | 0.00 USD | deriv |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 13 Dec 2024 | SALE | NOVAVAX INC | 4,150 | 9.02 USD | |
| 12 Nov 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 15,630 | 15.86 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | GLYCOMIMETICS INC | 40,000 | 0.00 USD | deriv |
| 29 Mar 2024 | GRANT_AWARD | GLYCOMIMETICS INC | 3,334 | 3.00 USD | |
| 29 Dec 2023 | GRANT_AWARD | GLYCOMIMETICS INC | 4,238 | 2.36 USD | |
| 30 Sept 2023 | GRANT_AWARD | GLYCOMIMETICS INC | 6,667 | 1.50 USD | |
| 10 Jun 2023 | EXERCISE | NOVAVAX INC | 3,100 | — | |
| 10 Jun 2023 | EXERCISE | NOVAVAX INC | 3,100 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | NOVAVAX INC | 7,710 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | NOVAVAX INC | 6,670 | 0.00 USD | deriv |
| 19 May 2023 | GRANT_AWARD | GLYCOMIMETICS INC | 35,000 | 0.00 USD | deriv |
| 02 Aug 2022 | INHERITANCE | GLYCOMIMETICS INC | 7,500 | 0.00 USD | |
| 15 Feb 2022 | INHERITANCE | GLYCOMIMETICS INC | 11,641 | 0.00 USD | |
| 17 Jun 2022 | EXERCISE | NOVAVAX INC | 700 | — | |
| 17 Jun 2022 | EXERCISE | NOVAVAX INC | 700 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | NOVAVAX INC | 3,100 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 May 2021.